Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Fertility-Sparing Treatment of Early Endometrial Cancer
NCT03538704Unknown
- Sponsor
- Peking University People's Hospital
- Start
- Jan 2015
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of metformin in endometrial cancer (EC) and Atypical endometrial hyperplasia (AEH) (2 arms), sponsored by Peking University People's Hospital. Primary endpoint: Complete response rate at 3 months. Status: unknown.
02
Drugs
metformin
03
Conditions
endometrial cancer (EC)Atypical endometrial hyperplasia (AEH)
Beyond the preview
Go deeper on NCT03538704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03538704.